Stock comparison
Eli Lilly
Sanofi
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
SNY
Sanofi
Market cap
$106.67B
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | SNY | Winner |
|---|---|---|---|
| Warren Buffett | 72B | 61C | LLY |
| Benjamin Graham | 86A | 40D | LLY |
| Philip Fisher | 86A | 53C | LLY |
| Peter Lynch | 74B | 39D | LLY |
| Joel Greenblatt | 78C | 39D | LLY |
| Charlie Munger | 85A | 48D | LLY |
| Terry Smith | 77C | 49D | LLY |
Side-by-side metrics
| Metric | LLY | SNY |
|---|---|---|
| Market cap | $1T | $106.67B |
| P/E (TTM) | 36.6x | 8.6x |
| EV/EBIT | 34.1x | 10.8x |
| ROIC (TTM) | 32.06% | 11.66% |
| Gross margin | 83.51% | 71.62% |
| Net margin | 34.98% | 17.59% |
| Revenue CAGR 5y | 23.17% | 4.5% |
| EPS CAGR 5y | 40.81% | 6.47% |
| Debt / Equity | 1.4x | 0.3x |
| Dividend yield | 0.62% | 5.57% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- Market cap$1Tvs $106.67B+89%
- EPS CAGR 5y40.81%vs 6.47%+84%
- Revenue CAGR 5y23.17%vs 4.5%+81%
- ROIC (TTM)32.06%vs 11.66%+64%
SNY leads on
- Dividend yield5.57%vs 0.62%+89%
- Debt / Equity0.3xvs 1.4x+80%
- P/E (TTM)8.6xvs 36.6x+77%
- EV/EBIT10.8xvs 34.1x+68%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.